New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
4Front Ventures Corp.
FFNTF
Shape
US Flag

PNK

Unprofitable

EPS improving

Unprofitable

EPS improving

49M

Drug Manufacturers - Specialty & Generic

Next Earning date - 18 Nov 2024

49M

Drug Manufacturers - Specialty & Generic

Next Earning date - 18 Nov 2024

0.05USD
0.00 ( 0.00%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-98%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

76%

Quote Panel

Shape
Updated October 25, 2024
1W 15.48 % 1M 7.40 % 3M -46.30 % 1Y -74.67 %

Key Metrics

Shape
  • Market Cap

    49.08M


  • Shares Outstanding

    913.92M


  • Share in Float

    308.06M


  • Dividende

    0


  • Earning Date

    18 Nov 2024


  • Price Target

    0.0537


  • Average Volume

    289543


  • Beta

    1.088


  • Range

    0.034-0.225


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://4frontventures.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.60x

P/S Ratio

-1.10x

P/B Ratio

-1.9

Debt/Equity

-110.4%

Net Margin

$-0.1

EPS

How FFNTF compares to sector?

P/E Ratio

Relative Strength

Shape

FFNTF

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$336M

Shape1703%

2025-Revenue

$0.18

Shape3496%

2025-EPS

$85M

Shape-2787%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

N/A

-0.01
vs -0.02

Q2.22

arrow
arrow

N/A

-0.01
vs -0.01

Q3.22

arrow
arrow

N/A

-0.01
vs -0.01

Q4.22

arrow
arrow

N/A

-0.04
vs -0.02

Q1.23

arrow
arrow

N/A

-0.02
vs -0.01

Q2.23

arrow
arrow

N/A

-0.02
vs -0.01

Q3.23

arrow
arrow

N/A

-0.10
vs -0.01

Q4.23

arrow
arrow

N/A

-0.01
vs -0.04

Q1.24

arrow
arrow

N/A

-0.02
vs -0.02

Q2.24

arrow
arrow

N/A

-0.01
vs -0.02

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+25%

32.5M  vs 25.9M

Q4.22

arrow
arrow

+11%

31.6M  vs 28.5M

Q1.23

arrow
arrow

+17%

30.4M  vs 26M

Q2.23

arrow
arrow

+8%

30.7M  vs 28.4M

Q3.23

arrow
arrow

-29%

23M  vs 32.5M

Q4.23

arrow
arrow

-32%

21.6M  vs 31.6M

Q1.24

arrow
arrow

-38%

18.8M  vs 30.4M

Q2.24

arrow
arrow

-39%

18.7M  vs 30.7M

Q3.24

arrow
arrow

+20%

27.5M  vs 23M

Q4.24

arrow
arrow

+50%

32.4M  vs 21.6M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-17%

-0.17
vs -0.12

Q4.22

arrow
arrow

-91%

-0.91
vs -0.17

Q1.23

arrow
arrow

-64%

-0.64
vs -0.91

Q2.23

arrow
arrow

-149%

-1.49
vs -0.64

Q3.23

arrow
arrow

+122%

1.22
vs -1.49

Q4.23

arrow
arrow

+10%

0.1
vs 1.22

Q1.24

arrow
arrow

+45%

0.45
vs 0.1

Q2.24

arrow
arrow

+11%

0.11
vs 0.45

Institutionnal OwnershipShape

status-upQoQ

Q4.21

arrow
arrow

3

3
vs 2

50%

Q1.22

arrow
arrow

3

3
vs 3

NA

Q2.22

arrow
arrow

1

1
vs 3

-67%

Q3.22

arrow
arrow

2

2
vs 1

100%

Q4.22

arrow
arrow

1

1
vs 2

-50%

Q2.23

arrow
arrow

1

1
vs NA

NA

Q4.23

arrow
arrow

1

1
vs NA

NA

Q1.24

arrow
arrow

1

1
vs 1

NA

Earnings Growth

Latest News